MedTrace Logo

Innovating CBT-I for Cancer Survivors: An Optimization Trial

NCT06181643 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-05-08

No results posted yet for this study

Summary

The overall goal of this project is to conduct a factorial, randomized controlled trial to optimize synchronous, virtual delivery of CBT-I for cancer survivors. The proposed project will yield multiple deliverables to innovate cancer survivorship care, chiefly an optimized, scalable, virtually-delivered intervention that addresses chronic insomnia, one of the most deleterious concerns among the growing demographic of cancer survivors in the U.S. Findings will inform future considerations for delivering CBT-I to cancer survivors.

Conditions

Interventions

BEHAVIORAL

Survivorship Sleep Program with Individual Delivery + No Booster Sessions

4 weekly SSP sessions delivered to individual participants (session durations approximately 45 min/session). No booster sessions.

BEHAVIORAL

Survivorship Sleep Program with Group Delivery + No Booster Sessions

4 weekly SSP sessions delivered to groups of participants (session durations approximately 90 min/session). No booster sessions.

BEHAVIORAL

Survivorship Sleep Program with Individual Delivery + 3 Booster Sessions

4 weekly SSP sessions delivered to individual participants (session durations approximately 45 min/session). 3 monthly booster sessions.

BEHAVIORAL

Survivorship Sleep Program with Group Delivery + 3 Booster Sessions

4 weekly SSP sessions delivered to groups of participants (session durations approximately 90 min/session). 3 monthly booster sessions.

Sponsors & Collaborators

Principal Investigators

  • Daniel Hall, PhD · Massachusetts General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-06
Primary Completion
2026-05-31
Completion
2026-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06181643 on ClinicalTrials.gov